BioLife Solutions, Inc. carries a market capitalization of 1.28B, placing it among publicly traded companies globally. Its enterprise value stands at 851.26M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.28B |
| Enterprise Value | 851.26M |
BioLife Solutions, Inc. currently has 48.83M shares outstanding.
| Shares Outstanding | 48.83M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 9.19, and the price-to-book ratio stands at -2.71.
| PE Ratio | N/A |
| PS Ratio | 9.19 |
| PB Ratio | -2.71 |
| P/TBV Ratio | 5.74 |
| P/FCF Ratio | 33.95 |
| P/OCF Ratio | 51.26 |
| EV / Sales | 8.53 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 31.11 |
BioLife Solutions, Inc. maintains a current ratio of 7.30, meaning it holds 7.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 7.30 |
| Quick Ratio | 5.15 |
| Debt / Equity | 3.99 |
| Debt / EBITDA | -1.31 |
| Interest Coverage | N/A |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -0.74 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 1.94 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.19 |
Over the trailing twelve months, BioLife Solutions, Inc. has paid 97,000.00 in income taxes, reflecting an effective tax rate of 16.63.
| Income Tax | 97,000.00 |
| Effective Tax Rate | 16.63 |
BioLife Solutions, Inc.'s stock has gained approximately 17.09287% over the past 52 weeks. The 50-day moving average sits at 22.74, while the 200-day moving average is 23.96.
| Beta (5Y) | N/A |
| 52-Week Price Change | 17.09287% |
| 50-Day Moving Average | 22.74 |
| 200-Day Moving Average | 23.96 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, BioLife Solutions, Inc. generated 99.77M in revenue and converted that into -2.96M in net income, yielding earnings per share of -0.22. EBITDA reached -11.36M, while operating income came in at -15.36M.
| Revenue | 99.77M |
| Gross Profit | 63.83M |
| Operating Income | -15.36M |
| Pretax Income | -10.40M |
| Net Income | -2.96M |
| EBITDA | -11.36M |
| EBIT | -15.36M |
| Earnings Per Share (EPS) | -0.22 |
BioLife Solutions, Inc. holds 81.00M in cash and equivalents against 14.86M in total debt, resulting in a net debt position of -20.32M. Total book value stands at -338.46M, with working capital of 114.97M providing operational flexibility.
| Cash & Cash Equivalents | 81.00M |
| Total Debt | 14.86M |
| Net Debt | -20.32M |
| Equity (Book Value) | -338.46M |
| Book Value Per Share | -7.04 |
| Working Capital | 114.97M |
BioLife Solutions, Inc. produced 17.90M in operating cash flow over the past twelve months. After subtracting -9.47M in capital expenditures, free cash flow totaled 8.43M - equivalent to 0.18 per share.
| Operating Cash Flow | 17.90M |
| Capital Expenditures | -9.47M |
| Free Cash Flow | 8.43M |
| FCF Per Share | 0.18 |
BioLife Solutions, Inc. operates with a gross margin of 63.97, reflecting its pricing power and cost economics. The operating margin of -15.39 and net profit margin of -2.97 provide insight into operational efficiency.
| Gross Margin | 63.97 |
| Operating Margin | -15.39 |
| Pretax Margin | -10.42 |
| Profit Margin | -2.97 |
| EBITDA Margin | -11.38 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 1.73 |
| FCF Yield | 2.95 |
BioLife Solutions, Inc.'s most recent stock split took place on January 29, 2014 with a 14:1 split ratio.
| Last Split Date | 1/29/2014 |
| Split Ratio | 14:1 |
BioLife Solutions, Inc. posts an Altman Z-Score of 17.67, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 17.67 |